Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 4Phase 1 3Phase NA 1Phase 2/3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Leukemia 5Lymphoma 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, T-Cell 2Burkitt Lymphoma 2Sezary Syndrome 1Sarcoma, Ewing 1Retinoblastoma 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Mycosis Fungoides 1Medulloblastoma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, B-Cell, Marginal Zone 1Central Nervous System Neoplasms 1Brain Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 3vocimagene amiretrorepvec 2Radiotherapy 2Lomustine 2Bevacizumab 2Vorinostat 1Vincristine 1Radiation 1Procarbazine 1Immunoglobulin G 1Flucytosine 1Disulfides 1DNA 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Astrocytoma × Vincristine × Clear all
NCT00003375 2024-07-09

Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma

Radiation Therapy Oncology Group

Phase 2/3 Completed
370 enrolled
CNS

Astrocytoma, Oligodendroglioma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡